Related Experiment Video
Updated: Aug 23, 2025
09:59
Preparation of Exosomes for siRNA Delivery to Cancer Cells
Published on: December 5, 2018
25.3K
An optimized exosome production strategy for enhanced yield while without sacrificing cargo loading efficiency.
Rongxin Zhang1,2, Te Bu3, Ruidan Cao4
1College of Life Science, Northwest University, Xi'an, 710069, China.
Journal of Nanobiotechnology
|October 30, 2022
Summary
Researchers developed an exosome booster strategy to increase exosome production by 14-fold. This method enhances exosome yield for therapeutic applications, overcoming a key challenge in clinical translation.
Area of Science:
- Biotechnology
- Cell Biology
- Nanomedicine
Background:
- Exosome-mediated mRNA delivery shows therapeutic potential but is limited by low exosome yield.
- Low exosome production hinders clinical translation of exosome-based therapies.
Purpose of the Study:
- To develop a strategy to significantly increase exosome production for therapeutic applications.
- To overcome the bottleneck of low exosome yield in exosome biogenesis.
Main Methods:
- Simultaneously reduced expression of genes inhibiting exosome biogenesis (Rab4 knockdown).
- Supplemented cell culture medium with red cell membrane particles (RCMPs).
- Evaluated exosome yield and therapeutic efficacy in a mouse model.
Main Results:
- Rab4 knockdown was most effective in promoting exosome biogenesis without cytotoxicity.
- Supplementing with RCMP further increased exosome production.
- The combined strategy (Rab4 knockdown + RCMP) achieved up to a 14-fold increase in exosome yield.
- Therapeutic exosomes loaded with Ldlr mRNA effectively alleviated liver steatosis and atherosclerosis in Ldlr-/- mice.
Conclusions:
- The exosome booster strategy significantly increases exosome yield, addressing a critical limitation for clinical translation.
- This approach facilitates the broader application of exosome-based therapies.
